4Hjelle B, Torres-Perez F. Hantaviruses in the americas and their role as emerging pathogens[J]. Viruses,2010,2(12):2559-2586.
5Hartman AL, Towner JS, Nichol ST. Ebola and marburg hemor- rhagic fever[J]. Clin Lab Med. 2010,30(1):161-177.
6Seah SK. Lassa, Marburg and Ebola: newly described African fe- vers[J]. Can Med Assoc J,1978, 118(4):347-350.
7Salvaggio MR, Baddley JW. Other viral bioweapons: Ebola and Marburg hemorrhagic fever[J]. Dermatol Clin,2004,22(3):291-302.
8Peters C J, Liu CT, Anderson GW, et al. Pathogenesis of viral hem- orrhagic fevers: Rift Valley fever and Lassa fever contrasted[J]. Rev Infect Dis, 1989,11(4):743-749.
9Flick R, Bouloy M. Rift Valley fever virus[J]. Curt Mol Med, 2005,5(8):827-834.
10Sanders E J, Tukei PM. Yellow fever: an emerging threat for Ke- nya and other east African countries. East Afr Med [J]. 1996,73 (1):10-12.
